MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Free Cash flow
-$7,430,261
Unit: Dollar
Positive Cash Flow Breakdown
    • Issuance of series d preferred s...
    • Proceeds from 2.5m streeterville...
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Capitalized software
    • Deferred offering costs
    • Principal repayments on the 2.5m...
    • Others
Cash Flow
2026-04-30
Net loss
-9,141,875
Depreciation
27,791
Amortization of debt discounts and deferred financing costs
495,950
Amortization - right-of-use assets, operating lease
103,559
Impairment of deferred offering costs
748,599
Stock-based compensation
1,312,383
Warrants issued to non-employees
108,335
Accounts receivable
-4,350
Inventory
5,362
Prepaid and other current assets
-237,863
Deferred offering costs
604,736
Capitalized software
715,191
Accounts payable
-334
Accrued liabilities
121,479
Other current liabilities
0
Lease liability, operating lease
-119,518
Net cash used in operating activities
-7,426,707
Purchase of property and equipment
3,554
Acquisition of intellectual property - intangibles
40,898
Net cash used in investing activities
-44,452
Issuance of common stock, net of fees
172,839
Issuance of series d preferred stock and warrants, net of issuance costs
5,549,207
Proceeds from shareholder note, net
0
Proceeds from 2.5m streeterville note, net-Streeterville Note One
0
Proceeds from 2.5m streeterville note, net-Streeterville Note Two
3,000,000
Principal repayments on the 2.5m streeterville note-Streeterville Note One
450,000
Principal repayments of financed insurance premiums
242,171
Net cash provided by investing activities
8,029,875
Net change in cash and cash equivalents during the year
558,716
Cash and cash equivalents, beginning of year
1,098,098
Cash and cash equivalents, end of year
1,656,814
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Issuance of series dpreferred stock and...$5,549,207 Proceeds from 2.5mstreeterville note,...$3,000,000 Issuance of common stock,net of fees$172,839 Net cash provided byinvesting activities$8,029,875 Canceled cashflow$692,171 Net change in cashand cash...$558,716 Canceled cashflow$7,471,159 Principal repayments onthe 2.5m...$450,000 Principal repayments offinanced insurance...$242,171 Stock-based compensation$1,312,383 Impairment of deferredoffering costs$748,599 Amortization of debtdiscounts and deferred...$495,950 Prepaid and othercurrent assets-$237,863 Accrued liabilities$121,479 Warrants issued tonon-employees$108,335 Amortization - right-of-useassets, operating lease$103,559 Depreciation$27,791 Accounts receivable-$4,350 Net cash used inoperating activities-$7,426,707 Net cash used ininvesting activities-$44,452 Canceled cashflow$3,160,309 Net loss-$9,141,875 Acquisition of intellectualproperty - intangibles$40,898 Purchase of property andequipment$3,554 Capitalized software$715,191 Deferred offering costs$604,736 Lease liability,operating lease-$119,518 Inventory$5,362 Accounts payable-$334

HeartSciences Inc. (HSCS)

HeartSciences Inc. (HSCS)